Evidence map›Paper›PMID 25648331›Full record

ArticleDisease markers2015

Microinflammation factors in the common diseases of the heart and kidneys.

Danijela Tasic, Sonja Radenkovic, Gordana Kocic, Marina Deljanin Ilic, Aleksandra Ignjatovic

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Danijela TasicClinical Centre of Nis, The Clinic of Nephrology, Dr. Zoran Djindjic Boulevard 48, 18000 Nis, Serbia.
Sonja RadenkovicClinical Centre of Nis, The Clinic of Nephrology, Dr. Zoran Djindjic Boulevard 48, 18000 Nis, Serbia ; The University of Nis, Faculty of Medicine, Dr. Zoran Djindjic Boulevard 81, 18000 Nis, Serbia.
Gordana KocicThe University of Nis, Faculty of Medicine, Dr. Zoran Djindjic Boulevard 81, 18000 Nis, Serbia.
Marina Deljanin IlicThe University of Nis, Faculty of Medicine, Dr. Zoran Djindjic Boulevard 81, 18000 Nis, Serbia.
Aleksandra IgnjatovicThe University of Nis, Faculty of Medicine, Dr. Zoran Djindjic Boulevard 81, 18000 Nis, Serbia.
University of Nis · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo determine levels of interleukin-8 (IL-8) and plasminogen activator inhibitor-1 (PAI-1) in different cardiorenal syndrome (CRS) modalities and to compare findings to some already investigated direct and indirect parameters of inflammation and atherosclerosis. MATERIALS AND

methodsTesting involved 114 examinees, divided into control and clinical groups suffering from different modalities and were formed according to the basis of a valid classification for CRS.

resultsC-reactive protein (CRP) was significantly higher in all CRSs in comparison to the control group (P < 0.05). PAI-1 in CRSs was statistically higher than in the control group. IL-8 was increased in all CRSs, and especially in CRS-5, where no significance was found. PAI-1 correlated with IL-8 in all CRSs, with significant value in CRS-2 and CRS-5. Correlation for PAI-1 and high-density lipoproteins (HDL) was found in CRS-4, while IL-8 was found to be related to CRP level in all CRSs, with significance only in CRS-1 (P < 0.001).

conclusionsC-reactive protein, IL-8, and PAI-1 could be useful for clinical differentiation of chronic modalities of CRSs. Inflammation was the most pronounced in CRS-4. Lipid status parameters could be useful for differentiation of CRSs. Furthermore, HDL in chronic primary kidney diseases and triglycerides and total cholesterol in CRS-5 could be valuable.

Indexed as

AdultAgedCardio-Renal SyndromeCase-Control StudiesC-Reactive ProteinFemaleHumansInflammationInterleukin-8Lipoproteins, HDLMaleMiddle AgedPlasminogen Activator Inhibitor 1C-Reactive ProteinInterleukin-8Lipoproteins, HDLPlasminogen Activator Inhibitor 1

Identifiers

PMID25648331
PMCPMC4310254
OpenAlexW2052185603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.